AVMA webinar outlines FDA guidance on compounding drugs
Veterinarians rely on many different types of medications to effectively treat their patients. When there isn’t an indexed drug available or one that has been approved by the U.S. Food and Drug Administration (FDA), they may turn to compounded drugs as an alternative.
In April 2022, the FDA released “Compounding Animal Drugs from Bulk Drug Substances,” guidance explaining the parameters within which veterinarians may use compounded drugs that are prepared from bulk drug substances. According to the American Veterinary Medical Association (AVMA), the FDA will begin enforcing this guidance through routine inspections starting in April 2023.
AVMA is now offering a new webinar on its platform to provide an overview of the FDA guidance.
FDA veterinarian Dr. Amber McCoig examines the policies included in the guidance and what they mean for veterinarians and their teams. She also discusses how the agency’s final guidance tries to balance the risks of compounding animal drugs from bulk substances when there is no FDA-approved drug available, and why the FDA can’t assure the safety, effectiveness, or quality of bulk drug substances.
The course is available to all veterinary team members free of charge. It offers 0.5 hours of continuing education credit.
Watch the webinar on the AVMA’s website.
Comments
Related Articles
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment